Update on Chinese Regulated Bioanalysis

Written by Dafang Zhong 1, Kelly Dong 2, Minji Wei 3, Jintong Li 4, Daniel Tang 5,*

AIdriven research projecting new drug developments, Pharmaceutical technology, Innovating medicine with advanced predictive analytics

This is article is available as part of our Focus on China, to view all other articles available as part of this feature click here. 1 Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences 2 GlaxoSmithKline R&D Shanghai 3 Institute of Clinical Pharmacology, Peking University 4 Beijing eStart Medical Technology 5 United-Power PharmaTech (*Corresponding author, [email protected]) Fast growing pharmaceutical R&D in China China has become the second largest economy this decade with an average GDP growth of > 8% in the past 30 years. Meanwhile the Chinese pharmaceutical market has grown to the second largest in the world...

To view this content, please register now for access

It's completely free